(Q46466275)

22 December 2017

title

Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade (English)

1 reference

22 December 2017

0 references

Shan Chen

1

1 reference

22 December 2017

Yan Ge

2

1 reference

22 December 2017

Jin Si

3

1 reference

22 December 2017

Abdalla Rifai

4

1 reference

22 December 2017

Lance D Dworkin

5

1 reference

22 December 2017

Rujun Gong

6

1 reference

22 December 2017

language of work or name

English

0 references

publication date

23 July 2008

1 reference

22 December 2017

published in

Kidney International

1 reference

22 December 2017

volume

74

1 reference

22 December 2017

issue

9

1 reference

22 December 2017

page(s)

1128-1138

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.2008.380

exact match

0 references

cites work

Oxygen radicals and signaling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Oxidant signals and oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

The cellular basis for diverse responses to oxygen

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

NADPH oxidases in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Redox-dependent transcriptional regulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2008.380

1 reference

7 January 2021

Redox-dependent signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Redox regulation of cellular functions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Angiotensin II-induced reactive oxygen species and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

The new heart failure guidelines: strategies for implementation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

ACE inhibition versus angiotensin receptor blockade: which is better for renal and cardiovascular protection?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Candesartan reduces superoxide production after global cerebral ischemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Additional antiproteinuric effect of ultrahigh dose candesartan: a double-blind, randomized, prospective study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Effects of pioglitazone and candesartan on renal fibrosis and the intrarenal plasmin cascade in spontaneously hypercholesterolemic rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Role of renin-angiotensin system and nuclear factor-kappaB in the obstructed kidney of rats with unilateral ureteral obstruction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Cell signaling. H2O2, a necessary evil for cell signaling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Pathophysiology of Progressive Nephropathies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Chronic kidney disease progression.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Oxidants in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Oxidative modification of proteins: age-related changes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Angiotensin II receptor blocker provides pancreatic beta-cell protection independent of blood pressure lowering in diabetic db/db mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Transcription factor-kappa B (NF-kappa B) and renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Redox redux: revisiting PTPs and the control of cell signaling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: targeting the inflamed vascular endothelium.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Activation of PI3K-Akt-GSK3beta pathway mediates hepatocyte growth factor inhibition of RANTES expression in renal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

O(2)-evoked regulation of HIF-1alpha and NF-kappaB in perinatal lung epithelium requires glutathione biosynthesis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Hepatocyte growth factor suppresses acute renal inflammation by inhibition of endothelial E-selectin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.380

7 January 2021

Identifiers

DOI

10.1038/KI.2008.380

1 reference

22 December 2017

PubMed ID

18650791

1 reference

22 December 2017